SUBSCRIBE
SUBSCRIBE

Organon

NEWS
Future Leaders of the Next Generation of Business People
Business
A Flurry of Leadership Changes in Biotech
The past few days has had a flurry of activity in the industry with leadership changes. Let’s take a look at some of those!
September 26, 2018
 · 
3 min read
 · 
Alex Keown
Biotech Beach
The Day In Review: Schering-Plough Corporation Buys Organon For $14.4 Billion
March 12, 2007
 · 
1 min read
BioForest
National Institutes of Health (NIH) Awards Nearly $11.5 Million To Support Science Education Programs
January 4, 2007
 · 
1 min read
Biotech Beach
The Day In Review: ImClone Systems Incorporated Loses Erbitux Patent Fight
September 19, 2006
 · 
1 min read
Load More
JOBS
IN THE PRESS
Press Releases
Organon Acquires TOFIDENCE™ (tocilizumab-bavi), a Commercialized Biosimilar to ACTEMRA® (tocilizumab) Injection, for Intravenous Infusion in the U.S.
April 1, 2025
 · 
13 min read
Press Releases
New Analysis of Organon’s VTAMA® (tapinarof) cream, 1% Phase 3 Data Shows Atopic Dermatitis Disease Activity Remained Low After Treatment-Free Interval in Adults and Children 2 Years of Age and Older
March 10, 2025
 · 
9 min read
Press Releases
Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2024
February 14, 2025
 · 
20 min read
Press Releases
Organon To Report Fourth Quarter and Full Year 2024 Results and Host Conference Call on February 13, 2025
January 23, 2025
 · 
3 min read
Press Releases
Organon To Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 19, 2024
 · 
1 min read
Press Releases
FDA Approves VTAMA® (tapinarof) cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older
December 16, 2024
 · 
9 min read
Press Releases
Update on FDA Review of VTAMA® (tapinarof) Cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older
November 6, 2024
 · 
6 min read
Press Releases
Organon Reports Results for the Third Quarter Ended September 30, 2024
October 31, 2024
 · 
19 min read
US FDA Accepts Biologics License Application (BLA) for HLX14, Biosimilar Candidate of PROLIA/XGEVA (denosumab)
October 30, 2024
 · 
5 min read
Press Releases
Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%
October 28, 2024
 · 
11 min read
Load More